FDA Urges Food Manufacturers to Reduce Sodium in Their Products

Share this content:
FDA Urges Food Manufacturers to Reduce Sodium in Their Products
FDA Urges Food Manufacturers to Reduce Sodium in Their Products

WEDNESDAY, June 1, 2016 (HealthDay News) -- The U.S. Food and Drug Administration wants the food industry to voluntarily reduce the amount of sodium in processed and commercially prepared food.

In draft voluntary guidelines issued Wednesday, the agency set both two-year and 10-year goals for lower sodium content in hundreds of processed and prepared foods. The aim is to reduce the risk of hypertension, cardiovascular disease, and stroke among Americans, according to the FDA.

Americans' average salt intake is about 3,400 mg a day, which is nearly 50 percent more than what experts recommend. The voluntary targets are meant to reduce Americans' daily salt intake to 3,000 mg in two years and 2,300 mg in the next decade, according to the FDA. The guidelines cover a wide range of foods, from bread to cold cuts, cereals, and snacks.

"Experts at the Institute of Medicine have concluded that reducing sodium intake to 2,300 mg per day can significantly help Americans reduce their blood pressure, and ultimately prevent hundreds of thousands of premature illnesses and deaths," Susan Mayne, Ph.D., director of the FDA's Center for Food Safety and Applied Nutrition, said in a statement. "Because the majority of sodium in our diets comes from processed and prepared foods, consumers are challenged in lowering their sodium intake themselves."

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Single-Payer Health System Bill Moves Forward in California

Single-Payer Health System Bill Moves Forward in California

Not yet clear where money for the single-payer system would come from

Regorafenib Approved for Hepatocellular Carcinoma

Regorafenib Approved for Hepatocellular Carcinoma

It is the first approved treatment for HCC in almost a decade

Three Anti-VEGF Treatments Effective for Diabetic Retinopathy

Three Anti-VEGF Treatments Effective for Diabetic Retinopathy

Rates of worsening low in patients receiving aflibercept, bevacizumab, or ranibizumab

is free, fast, and customized just for you!

Already a member?

Sign In Now »